Healthcare Analysts, along with Asim Roy, MD, discuss Avadel Pharmaceuticals’ Lumryz for treatment of Narcolepsy on an Analyst/Industry conference call to be held on January 26.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on AVDL:
- Avadel Pharmaceuticals announces publication on oxybate
- Avadel Pharmaceuticals Announces Publication of Real-World Data Highlighting the Risk of Accidental Dosing Errors with Immediate-Release Twice-Nightly Oxybates
- Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- Largest borrow rate increases among liquid names
- Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations